Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000899140-22-000756
Filing Date
2022-10-24
Accepted
2022-10-24 16:37:11
Documents
2
Group Members
CUBIST SYSTEMATIC STRATEGIES, LLCPOINT72 CAPITAL ADVISORS, INC.STEVEN A. COHEN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G pt7213ga.htm SC 13G 54680
2 JOINT FILING AGREEMENT pt7213gb.htm EX-99.1 2809
  Complete submission text file 0000899140-22-000756.txt   59202
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Subject) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88651 | Film No.: 221326369
SIC: 2834 Pharmaceutical Preparations

Mailing Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902
Business Address 72 CUMMINGS POINT ROAD STAMFORD CT 06902 203-890-2000
Point72 Asset Management, L.P. (Filed by) CIK: 0001603466 (see all company filings)

EIN.: 465064661 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G